Consequently, the use of medications or substances targeting cellular zinc transporters such as ZIP and ZnT transporters, TRPM7 channels, and transcription factors like Metal-responsive transcription factor (MTF)-1, shows promising potential as a therapeutic approach for treating cardiac dysfunction, including arrhythmias. Here, TRPM7 is linked to cardiac arrhythmia.